Abstract
Background & Aims
Food additives, such as emulsifiers, stabilizers, or bulking agents, are present in the Western diet and their consumption is increasing. However, little is known about their potential effects on intestinal homeostasis. In this study we examined the effect of some of these food additives on gut inflammation.
Methods
Mice were given drinking water containing maltodextrin (MDX), propylene glycol, or animal gelatin, and then challenged with dextran sulfate sodium or indomethacin. In parallel, mice fed a MDX-enriched diet were given the endoplasmic reticulum (ER) stress inhibitor tauroursodeoxycholic acid (TUDCA). Transcriptomic analysis, real-time polymerase chain reaction, mucin-2 expression, phosphorylated p38 mitogen-activated protein (MAP) kinase quantification, and H&E staining was performed on colonic tissues. Mucosa-associated microbiota composition was characterized by 16S ribosomal RNA sequencing. For the in vitro experiments, murine intestinal crypts and the human mucus-secreting HT29-methotrexate treated cell line were stimulated with MDX in the presence or absence of TUDCA or a p38 MAP kinase inhibitor.
Results
Diets enriched in MDX, but not propylene glycol or animal gelatin, exacerbated intestinal inflammation in both models. Analysis of the mechanisms underlying the detrimental effect of MDX showed up-regulation of inositol requiring protein 1β, a sensor of ER stress, in goblet cells, and a reduction of mucin-2 expression with no significant change in mucosa-associated microbiota. Stimulation of murine intestinal crypts and HT29-methotrexate treated cell line cells with MDX induced inositol requiring protein 1β via a p38 MAP kinase–dependent mechanism. Treatment of mice with TUDCA prevented mucin-2 depletion and attenuated colitis in MDX-fed mice.
Conclusions
MDX increases ER stress in gut epithelial cells with the downstream effect of reducing mucus production and enhancing colitis susceptibility.
Keywords: Colitis, IBD, Unfolded Protein Response, Intestinal Epithelium
Abbreviations used in this paper: ATF, activating transcription factor; Chop, C/EBP homologous protein; DSS, dextran sodium sulfate; ER, endoplasmic reticulum; Ern-1, endoplasmic reticulum to nucleus signaling 1; GEL, animal gelatin; Grp78, glucose-regulated protein; HT29-MTX, HT29-methotrexate treated cell line; IBD, inflammatory bowel disease; IEC, intestinal epithelial cells; IL, interleukin; IRE, inositol-requiring enzyme; Lcn-2, lipocalin-2; LPMC, lamina propria mononuclear cells; MAPK, mitogen-activated protein kinase; MDX, maltodextrin; Muc-2, Mucin-2; OTU, operational taxonomic unit; PBS, phosphate-buffered saline; PCR, polymerase chain reaction; PG, propylene glycol; p-p38, phosphorylated p38; siRNA, small interfering RNA; TUDCA, tauroursodeoxycholic acid; UPR, unfolded protein response
Graphical abstract
See editorial on page 475.
Summary.
This study reports that the polysaccharide maltodextrin, which is a common additive used in Western diet for food processing, triggers endoplasmic reticulum stress in goblet cells. Our data support the hypothesis that a Western diet rich in maltodextrin can contribute to gut disease susceptibility and can help design preventive programs for subjects at high risk to develop inflammatory bowel diseases.
Inflammatory bowel disease (IBD) is a term used to describe 2 chronic inflammatory disorders of the gut, namely ulcerative colitis and Crohn's disease.1 Although the etiology of IBD remains unknown, accumulating evidence has suggested that the pathologic process results from an interaction between environmental and genetic factors, which trigger an excessive intestinal immune response against components of the gut microflora.2, 3 In the past decades, there has been an increase in the incidence of IBD in previously low-incidence regions of the world (eg, Asia), coincident with these countries becoming more westernized.4, 5, 6, 7 Epidemiologic studies have indicated that Western dietary factors, particularly those that result in being overweight or obese, can influence the development of IBD.8, 9 However, it remains unclear which dietary factors have a causative role in IBD and how each of these factors may affect intestinal homeostasis.10, 11 A Western diet can shape the intestinal microbiota and promote overgrowth of microorganisms potentially involved in the development of IBD.12, 13 Indeed, mice given a fat-based diet showed increased abundance and activity of Bilophila wadsworthia owing to changes in the production of bile acids, and consequently exacerbation of experimental colitis.12 Another possibility is that Western diet–related elements, such as high dietary salt and saturated fatty acids, can directly target mucosal immune cells and potentate pathogenic responses.14, 15, 16 In addition, diet can have a direct impact on the mucus layer of the gastrointestinal tract.17, 18
A Western diet also is rich in food additives, which commonly are added as stabilizers, coating materials, or bulking agents in prepackaged foods. Although the US Food and Drug Administration recognizes these dietary elements as safe, their use has been linked to the development of intestinal pathologies in both animals and human beings.19, 20, 21, 22, 23 For example, synthetic dietary emulsifiers polysorbate 80 and carboxymethylcellulose act directly on human microbiota to increase its proinflammatory potential.19 It also has been shown that the polysaccharide maltodextrin (MDX), which is commonly used as a filler and thickener during food processing, can alter microbial phenotype and host antibacterial defenses. MDX expands the Escherichia coli population in the ileum and induces necrotizing enterocolitis in preterm piglets.24 Nickerson and McDonald21 reported that MDX increases cellular adhesion of the “adherent and invasive E coli” strain and in vivo studies have shown an increased load of cecal bacteria in MDX-fed mice upon oral infection with Salmonella, even though MDX by itself did not induce disease.20
In this study, we therefore investigated whether food additives used in the Western diet can perturb intestinal homeostasis and exacerbate gut inflammation.
Results
MDX-Enriched Diet Exacerbates Intestinal Inflammation
To investigate whether food additives promote and/or exacerbate intestinal inflammation, wild-type Balb/c mice were exposed to MDX (5%), propylene glycol (PG) (0.5%), and animal gelatin (GEL) (5 g/L) diluted in drinking water. The selected compounds induced neither clinical and histologic signs of intestinal inflammation nor changes in inflammatory cytokines (Figure 1A–C). Lipocalin-2 (Lcn-2) is a secretory protein produced mainly by neutrophils and released in the feces after induction of colitis.25 Therefore, Lcn-2 is considered a sensitive and noninvasive biomarker of intestinal inflammation. Analysis of Lcn-2 in stool samples collected from mice exposed to MDX (5%), PG (0.5%), and GEL (5 g/L) showed no significant change as compared with control mice, thus confirming the absence of colitis in mice fed such additives (Figure 1D). However, MDX-fed mice developed a more severe colitis when challenged with dextran sulfate sodium (DSS), as shown by significantly greater weight loss (Figure 2A), more pronounced infiltration of inflammatory cells, and greater epithelial damage (Figure 2B and C). The MDX-fed mice also showed up-regulation of interleukin (IL)1β and Lcn-2 as compared with mice receiving PG- or GEL-enriched diet or controls (Figure 2D and E). To ascertain at which concentration MDX exacerbated experimental colitis, we fed mice with MDX concentrations ranging from 1% to 5%. The deleterious effect of MDX on intestinal inflammation was more evident when it was used at a concentration of 5%, even though mice given 3% MDX showed a more pronounced inflammatory infiltrate as compared with control mice receiving drinking water (Figure 2F and G). Therefore, all subsequent experiments were performed with 5% MDX.
To exclude that the more severe colitis in MDX-treated mice was owing to increased uptake of DSS, we used another model of intestinal inflammation induced by a single subcutaneous injection of indomethacin. MDX-fed mice showed a more pronounced ileal mucosal injury compared with controls (Figure 2H and I). Altogether, these data indicate that consumption of MDX in drinking water exacerbates gut inflammation.
MDX Activates an Endoplasmic Reticulum Stress Response in Intestinal Epithelial Cells
To dissect the mechanisms by which MDX enhances susceptibility to intestinal damage, we performed a microarray analysis of colonic samples isolated from mice receiving MDX. Several genes involved in the lipid and carbohydrate metabolism and in protein glycosylation were up-regulated in MDX-treated mice (Figure 3A). Mice given MDX also showed increased transcripts of molecules involved in the unfolded protein response (UPR), usually activated upon accumulation of unfolded proteins in the endoplasmic reticulum (ER), a phenomenon termed ER stress. Activation of the UPR pathway promotes translational attenuation, refolding of unfolded proteins, and degradation of irreversibly unfolded proteins, with the downstream effect of restoring ER function. Among the UPR-related genes, Ern-2, which encodes for inositol-requiring enzyme (IRE)1β protein, was the most differentially expressed gene (Figure 3A). Real-time polymerase chain reaction (PCR) assay of colonic samples confirmed the microarray results and showed up-regulation of Ern-1 and Xbp1s, 2 other IRE1/UPR-related genes (Figure 3B). In contrast, MDX caused no significant change in glucose-regulated protein (Grp78), activating transcription factor 6 (ATF6), ATF4, and CCAAT/enhancer-binding protein homologous protein (Chop) (Figure 3C), suggesting that MDX specifically induces IRE1-dependent signal transduction events. Further analysis of RNA transcripts in intestinal epithelial cells (IECs) and lamina propria mononuclear cells (LPMCs) isolated from colonic samples showed that induction of IRE1β/IRE1α was restricted to the intestinal epithelium compartment (Figure 3D). In vitro stimulation of intestinal crypts from untreated mice with MDX enhanced RNA transcripts for Ern-1, Ern-2, and Xbp1s (Figure 3E).
MDX-Enriched Diet Alters the Intestinal Mucus Barrier
IRE1β expression is restricted to the ER membrane of goblet cells in the small intestine and colon.26 The major macromolecular component of the gut mucus layer is the mucin glycoprotein Mucin-2 (Muc-2), which contains cysteine-rich and highly glycosylated domains and requires extensive post-translational modification within the ER and Golgi.27 The complexity of the mucin protein and the high secretory output of the goblet cells make Muc-2 prone to misfolding. Increased accumulation of Muc-2 precursors in the ER of goblet cells leads to a reduction of mucin secretion.28 Immunofluorescence analysis of colonic sections showed that MDX markedly reduced Muc-2 staining, as well as expression of glycosylated (mature) Muc-2 (Figure 4A). Moreover, periodic acid-Schiff/Alcian blue staining confirmed the negative effect of a MDX-enriched diet on mucus content (Figure 4B). In contrast, MDX up-regulated Muc-2 RNA transcripts (Figure 4C), a finding that could reflect activation of a compensatory mechanism to the reduced Muc-2 protein secretion. Mice receiving PG or GEL showed no mucus depletion in the colon (Figure 4D). RNA transcripts for zonulin-1, zonulin-2, claudin-2, and claudin-7 remained unchanged after MDX exposure (Figure 4E). Enhanced staining for cleaved caspase-3, indicative of induction of intestinal epithelial apoptosis, was seen in colonic sections of MDX-treated mice (Figure 4F).
Induction of ER Stress by MDX Is Mediated by p38 Mitogen-Activated Protein Kinase
We then examined the pathway(s) whereby MDX induces ER stress. Stimulation of the mucus-secreting HT29-methotrexate treated cell line (HT29-MTX) cell line with 3% and 5% MDX up-regulated Ern-2 RNA transcripts (Figure 5A). To be consistent with the in vivo results, the subsequent in vitro studies were performed using 5% MDX. Increased concentrations of solutes, such as glucose, in the extracellular compartments were associated with augmented hypertonicity. Because hypertonic stress is sensed through the mitogen-activated protein kinase (MAPK) signaling pathway,29, 30 we investigated the involvement of such a pathway in the MDX-mediated IRE1β induction. Treatment of HT29-MTX cells with MDX caused a time-dependent increase in the expression of phosphorylated (p)-p38, while extracellular signal–regulated kinase 1/2 and c-Jun N-terminal kinase activation remained unchanged (Figure 5B). Pharmacologic inhibition of p38 down-regulated MDX-induced Ern-2 RNA expression (Figure 5C). Similar results were seen in MDX-treated cells transfected with p38 small interfering RNA (siRNA) (Figure 5D). Immunofluorescence of mouse colonic sections showed that daily consumption of MDX enhanced p-p38 expression in epithelial cells (Figure 5E).
ER Stress Inhibition Improves Colitis in MDX-Fed Mice
To mechanistically prove that the enhanced susceptibility of mice to colitis after MDX administration relies on the ER stress/UPR pathway, we inhibited ER stress with the chemical chaperone tauroursodeoxycholic acid (TUDCA). First, we confirmed that TUDCA inhibited ER stress because pretreatment of HT29-MTX cells with TUDCA significantly reduced MDX-mediated Ern-2 RNA expression (Figure 6A). Next, we showed that administration of TUDCA to MDX-treated mice resulted in diminished induction of Ern-2, Ern-1, and Xbp1s RNA expression and normalization of Muc-2 production (Figure 6B and C). In these experiments, TUDCA administration was started at day 21 because our data showed initial signs of ER stress at this time point after MDX administration (personal unpublished observations). Finally, we tested the modulatory effect of TUDCA on the course of DSS colitis. Mice receiving TUDCA showed a marked attenuation of DSS colitis after MDX administration, as evidenced by less changes in body weight, improved histology (Figure 6D–F), and lower IL1β and Lcn-2 transcripts (Figure 6G and H).
MDX-Enriched Diet Does Not Affect Mucosa-Associated Microbiota
Interrogation of microbiota composition with 16S RNA sequencing in colonic samples showed that MDX-fed mice did not show any changes in microbiota composition in terms of phyla and related classes (Figure 7A and B), with low frequency (<0.1%) of the genus E coli among groups. TUDCA treatment was associated with no change in microbiota composition (Figure 7A and B).
Prolonged MDX-Enriched Diet Induces Low-Grade Intestinal Inflammation
Studies in mucin-deficient mice indicated that persistent mucus reduction can lead to the development of intestinal pathology.28, 31, 32, 33 Therefore, we assessed whether prolonged a MDX-enriched diet could favor the initiation of intestinal inflammation. Mice fed with MDX for 10 weeks showed no significant change in body weight and stool consistency (Figure 8A and B). However, such animals showed low-grade intestinal inflammation, which was characterized by focal inflammatory infiltrates, distortion of gland architecture, edema, and increased transcripts for IL1β, Lcn-2, and Ern-2 as compared with control mice (Figure 8C–E). As expected, mice receiving MDX had a marked reduction of Muc-2 protein (Figure 8F).
Because recent studies reported that low-grade inflammation induced by food additives was associated with metabolic alterations,19, 22 we investigated whether a prolonged MDX-enriched diet could alter blood glycemic levels. Data shown in Figure 8G indicate that the 15-hour fasting blood glucose level was higher in MDX-treated mice as compared with controls (Figure 8G).
Discussion
This study was performed to ascertain whether food additives commonly used in the Western diet could promote/exacerbate gut inflammation. Initial experiments showed that daily consumption of each of 3 common food additives, namely MDX, PG, and GEL for 45 days, did not induce overt colitis. However, mice given MDX, but not PG or GEL, showed increased severity of intestinal inflammation after DSS or indomethacin administration. The concentration of MDX selected for this study (ie, 5%) is equivalent to levels commonly found in infant formulas,24 even though it is highly likely that the amount of MDX reaching the distal intestine is lower than what was administered to mice. We next performed a microarray analysis of colon samples from MDX-treated mice to determine the mechanisms involved. Among the most up-regulated genes in the MDX-treated mice was Ern-2, which encodes for IRE1β, a sensor of ER stress that mitigates the uncontrolled activation of ER stress response in epithelial cells. Indeed, IRE1β is expressed in intestinal epithelial and airway mucus cells, where it promotes efficient protein folding and secretion of mucins by regulating the level of Muc-2 RNA.26, 34 Therefore, it is plausible that IRE1β up-regulation in the colons of MDX-fed mice reflects the activation of a counter-regulatory mechanism that attempts to limit ER stress response in goblet cells. Next, we evaluated whether MDX altered the production of mucus. Mice receiving MDX had marked reduction of O-linked, glycosylated, mature Muc-2, even though they showed increased Muc-2 RNA expression. Altogether, these results indicate that mucus depletion seen in MDX-fed mice reflects alterations in Muc-2 maturation/folding and secretion rather than being a consequence of a defect in goblet cell development. In line with the earlier-described findings, in vitro stimulation of murine intestinal crypts and mucus-secreting HT29-MTX cells with MDX increased IRE1β expression.
Our data suggest a model in which MDX-enriched diet triggers the ER stress sensor IRE1β in intestinal epithelial cells via p38 MAPK, because MDX increased the expression of p-p38 in mice and HT29-MTX cells. Moreover, pharmacologic inhibition of p38 with SB202190, which is known to interfere with p38 MAP kinase activity35 and to partially impair p38 phosphorylation through an indirect or feedback response mechanism,36, 37, 38 as well as p38 knock-down using a specific siRNA abrogated MDX-driven IRE1β expression. The effect of MDX on Muc-2 content appears to be specific because MDX did not affect expression of other epithelial proteins (ie, defensins, zonulins, and claudins).
We surmise that induction of ER stress in goblet cells is functionally relevant to the detrimental effects of MDX because pretreatment of mice with TUDCA, a chemical chaperone that inhibits ER stress, prevented MDX-mediated Ern-2 RNA overexpression and Muc-2 protein down-regulation, as well as the detrimental effect of MDX on DSS-induced colitis. Because TUDCA was reported to exert other protective functions in the gut (eg, reduction of proinflammatory cytokine synthesis and improvement of intestinal barrier function),39, 40 we cannot exclude the possibility that TUDCA-mediated prevention of intestinal damage in colitic mice receiving MDX can in part rely on other potential regulatory effects of the compound.
Our data support previous studies showing that goblet cells are one of the major cells that tend to undergo ER stress in the intestinal epithelium.28, 41 This diminishes the integrity of the mucus barrier by reducing biosynthesis and mucin secretion.28 The ability of MDX to promote ER stress appears unique because other food additives, such as titanium dioxide, have been reported to damage intestinal epithelial cells through a mechanism mediated by oxidative stress and independent of ER stress.42 After synthesis by goblet cells, Muc-2 is secreted into the lumen and forms a protective mucus gel layer that acts as a selective barrier to protect the epithelium from mechanical stress, noxious agents, bacteria, and other pathogens.43, 44, 45 Indeed, in the absence of a mucus layer, as in Muc-2–deficient mice, colonization of enteric pathogens occurs to a greater extent and more readily than in wild-type animals.46 Moreover, after infection with specific pathogens (eg, Citrobacter rodentium, Entamoeba histolytica), Muc-2–deficient mice show greater damage to the epithelium and have more colonic ulceration.47, 48
Mucosa-associated microbiota composition remained unchanged on a MDX-enriched diet, arguing against the hypothesis that mucosal dysbiosis plays a key role in the negative effect of MDX on mucus formation. Our results differ from recently published data showing that dietary emulsifiers promote modest disturbances of the luminal microbiota, thus resulting in low-grade inflammation in wild-type mice, inducing severe alterations of gut microbiota composition, promoting robust colitis in mice lacking the immune-regulatory cytokine IL10, and negatively impacting the luminal microbiota composition in human beings.19, 49 Overall, the earlier-described observations indicate that multiple dietary components can alter intestinal homeostasis, contributing to the initiation and progression of pathologic conditions. In this context, it has been proposed that changes in the mucus barrier or biosynthesis of mucins play a role in the onset and persistence of IBD. In particular, in the inflamed colons of patients with ulcerative colitis, the mucus layer is thin owing to decreased Muc-2 production and secretion resulting from goblet cell depletion.46 Indeed, these cells contain fewer mucin granules, which are filled with a nonglycosylated Muc-2 precursor, a finding that resembles that seen in mice exposed to MDX. Similarly, there is evidence that alterations in the amount and composition of the mucus barrier lead to IBD-like pathology in mice and that decreased Muc-2 output resulting from ER stress can diminish the mucus barrier and ultimately trigger inflammation.28 This hypothesis is supported further by our demonstration that persistent mucus depletion in mice receiving a long-term MDX diet leads to low-grade inflammation.
In conclusion, this study shows that a MDX-enriched diet reduces the intestinal content of Muc-2, thus making the host more sensitive to colitogenic stimuli. These data together with the demonstration that MDX can promote epithelial intestinal adhesion of pathogenic bacteria21 supports the hypothesis that Western diets rich in MDX can contribute to gut disease susceptibility.
Materials and Methods
Mice
Balb/c mice (age, 6–7 wk) were purchased from Charles River Laboratories Italia Srl (Rozzano (MI), Italy) and hosted in the animal facility at the University of Rome Tor Vergata (Rome, Italy). All in vivo experiments were approved by the animal ethics committee according to Italian legislation on animal experimentation.
Food Additive Treatment and Experimental Gut Inflammation
MDX (dextrose equivalent, 4.0–7.0; #419672) and propylene glycol (>99.5% Food Chemicals Codex; #W294004) were purchased from Sigma (Milan, Italy). Animal gelatin from bovine and porcine bones was purchased from Honeywell Fluka (Milan, Italy) (#53028). Mice were exposed to MDX (concentration range, 1%–5%), PG (0.5%), and GEL (5 g/L) in drinking water for 45 days. Water was changed every second day. During the last 10 days, animals received DSS (1.75%, #160110; MP Biomedicals, Santa Ana, CA) either in normal drinking water, or MDX-, PG-, or GEL-enriched drinking water. Mice were weighed daily. Mice were killed after 10 days of treatment with DSS and colon samples were collected for histology, protein and RNA extraction, and isolation of IECs and LPMCs. In parallel, mice receiving a MDX-enriched diet, together with control mice, were given 250 mg/kg TUDCA (Carbosynth Ltd, Berkshire, UK) intraperitoneally every other day starting from day 21 of diet.
In additional experiments, mice were exposed to drinking water in the presence or absence of MDX 5% for 35 days and then injected subcutaneously with indomethacin (5 mg/kg, #I7378; Sigma). Mice were killed 24 hours later and ileal samples were collected for histologic analysis.
Cell Isolation and Cultures
IECs and LPMCs were isolated from murine colons as described previously.50 Cells were resuspended in lysis buffer supplemented with 1% β-mercaptoethanol and stored at -80°C until RNA extraction. To isolate murine crypts, fresh colon specimens were cut in 5-mm size fragments and incubated in Dulbecco’s modified Eagle medium containing 15 mmol/L EDTA for 1 hour at 4°C. The resulting crypts were stimulated with MDX 5% for 30 minutes and then resuspended in lysis buffer supplemented with 1% β-mercaptoethanol and stored at -80°C until RNA extraction.
The mucous-secreting HT29-MTX cell line was obtained from the European Collection of Authenticated Cell Cultures (Public Health England, Porton Down, Salisbury, UK). Cells were cultured in Dulbecco’s modified Eagle medium supplemented with 10% fetal bovine serum, penicillin (0.1%), and streptomycin (0.1%). Subconfluent cells were cultured in the presence of increasing concentrations of MDX (from 1% to 5%) for 1 hour or with MDX 5% for different time points (5 minutes, 15 minutes, 30 minutes, and 1 h). In some experiments, HT29-MTX cells were pretreated with TUDCA (10 μmol/L) or a p38-MAPK inhibitor (S202190; Calbiochem, San Diego, CA) for 1 hour or transfected with p38 or a control siRNA (Santa Cruz Biotechnology, Dallas, TX) using Lipofectamine 3000 reagent (Invitrogen, Carlsbad, CA). After stimulation with MDX, cells were collected and pellets were immediately stored at -80°C for protein extraction, or resuspended in lysis buffer supplemented with 1% β-mercaptoethanol and stored at -80°C until RNA extraction.
Transcriptome Analysis
Total RNA was extracted from colon samples using the PureLink Purification technology kit with the RNase-free DNase set (Thermo Fisher Scientific, Monza, Italy). Samples with quantified complementary DNA were sequenced in the Microarray Unit of the Consortium for Genomic Technologies (Milan, Italy) by hybridization to GeneChip (Cogentech, Milan, Italy) Mouse Gene 2.0 ST microarrays. Signal intensities of fluorescent images produced during GeneChip hybridizations were read by an Affymetrix (Santa Clara, CA) Model 3000 Scanner. Transcripts were selected on base of fold change value of 2 or higher. All the transcripts present on the GeneChip array were mapped to related classes by Gene Onthology, which provided the fold change generated from the comparison between MDX vs water. All the lists were annotated using the latest version of GeneChip Mouse Gene ST 2.0 annotations provided by NetAffx (Affymetrix) portal. The microarray data set has been deposited in the Gene Expression Omnibus databank (accession no. GSE117639; https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE117639).
Real-Time PCR
Total RNA was isolated from colon biopsy specimens and cells using PureLink Purification technology (Thermo Fisher Scientific). A constant amount of RNA (1 μg/sample) was retrotranscribed into complementary DNA. Reverse-transcription was performed with Oligo(dT) primers and with M-MLV reverse-transcriptase (Thermo Fisher Scientific). Real-time PCR was performed for murine IL1β, Lcn-2, tumor necrosis factor-α, interferon-γ, IL17A, endoplasmic reticulum to nucleus signaling 1 (Ern-1), Ern-2, β-defensin-1, zonulin-1, claudin-7, spliced X-box binding protein 1, activating transcription factor 6, activating transcription factor 4, and Chop using the IQ SYBR Green Supermix (Bio-Rad Laboratories, Milan, Italy), and for murine zonulin-2, claudin-2, and human Ern-2 using TaqMan Gene Expression Assays (Thermo Fisher Scientific). RNA expression was calculated relative to the β-actin gene using the Delta-Delta Cycle threshold algorithm.
Quantification of Fecal Lipocalin-2 by Enzyme-Linked Immunosorbent Assay
Fecal samples were weighted and resuspended in phosphate-buffered saline (PBS) containing 0.1% Tween 20 at a final concentration of 100 mg/mL. Samples then were vortexed for 20 minutes and centrifugated for 10 minutes at 14,000g and 4°C. Supernatants then were collected and stored at -80°C until analysis. Lcn-2 protein levels were quantified using the Duoset murine Lcn-2 enzyme-linked immunosorbent assay kit (R&D Systems, Minneapolis, MN), and optical density was read at 450 nm.
Western Blot
Cells were lysed on ice in buffer containing 10 mmol/L HEPES (pH 7.9), 10 mmol/L potassium chloride, 0.1 mmol/L EDTA, 0.2 mmol/L ethylene glycol-bis (β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid, and 0.5% Nonidet P40 supplemented with 1 mmol/L dithiothreitol, 10 mg/mL aprotinin, 10 mg/mL leupeptin, 1 mmol/L phenylmethylsulfonyl fluoride, 1 mmol/L Na3VO4, and 1 mmol/L sodium fluoride. Lysates were clarified by centrifugation and separated on sodium dodecyl sulfate–polyacrylamide gel electrophoresis. Blots were incubated with antibodies against p-p38 (1:1000, #4511S; Cell Signalling Technology, Danvers, MA), p38 (#sc-7972), phosphorylated extracellular signal–regulated kinase-1/2 (#sc-7383), phosphorylated c-Jun N-terminal kinase (#sc-6254) (1:500; all from Santa Cruz Biotechnology), and β-actin antibody (1:5000, #A544; Sigma), followed by a secondary antibody conjugated to horseradish peroxidase (1:20,000; Dako, Santa Clara, CA).
Histopathologic Scoring and Immunohistochemistry
Cryosections of colon and ileum samples were stained with H&E and scored in blinded fashion on the basis of changes of the epithelium and cell infiltration, as previously described.51 Cryosections of colon specimens were stained with rabbit anti-cleaved caspase-3 antibody (1:150, #9661S; Cell Signalling Technology) and positive cells were visualized using MACH4 Universal Horseradish-Peroxidase Polymer kit with 3,3′-diaminobenzidine tetra hydrochloride (#M4BD534G; Biocare Medical, Pacheco, CA).
Immunofluorescence and Periodic Acid-Schiff–Alcian Blue Staining
Cryosections of colon were placed in methanol–Carnoy’s fixative solution (60% methanol, 30% chloroform, 10% glacial acetic acid) for 2 hours at room temperature for Muc-2 detection or in paraformaldehyde 4% for 10 minutes at room temperature for p-p38 staining. Sections then were washed in PBS 1 time and permeabilized with 0.1% Triton (Segrate (MI), Italy) X-100 for 20 minutes. Blocking procedure (bovine serum albumin 1%, Tween 0.1%, glycine 2%) was performed for 1 hour at room temperature and rabbit primary antibody against Muc-2 (1:100, #sc-15334; Santa Cruz Biotechnology), rabbit primary antibody against p-p38 (1:100, #4511S; Cell Signalling Technology), and O-linked sugar residues (1:500, lectin from Dolichos biflorus [horse gram], #L6533; Sigma) were incubated overnight at 4°C. After washing with PBS 1 time, the secondary antibody goat anti-rabbit Alexa 488 (1:2000, #A11008; Invitrogen) and streptavidin Alexa 568 (1:2500, #S11226; Thermo Fisher Scientific) were applied for 2 hours at room temperature. Slides were washed with PBS 1 time and mounted using Prolong gold antifade reagent with 4′,6-diamidino-2-phenylindole (#P36931; Invitrogen) and analyzed by a Leica DMI4000 B microscope with Leica (Wetzlar, Germany) application suite software (V4.6.2). To visualize goblet cells, cryosections of colon samples were placed in methanol–Carnoy’s fixative solution for 2 hours at room temperature and stained with the periodic acid-Schiff/Alcian blue stain kit (#04-163802; Bio-Optica, Milan, Italy).
Microbiota Analysis by 16S Ribosomal RNA Gene Sequencing
16S Ribosomal RNA gene sequence analysis was performed by Polo d’Innovazione di Genomica, Genetica e Biologia (Siena, Italy) using genomic DNA extracted from colon biopsy specimens. The libraries were prepared in accordance with the Illumina (San Diego, CA) 16S Metagenomic Sequencing Library Preparation Guide (part # 15044223 Rev. B) and the Nextera XT Index Kit (Illumina). PCR was performed to amplify template from the DNA samples using region of interest–specific primers (16S V4 region) with overhang adapters attached. A first purification step used AMPure XP (Beckman Coulter, Brea, CA) beads to purify the 16S amplicon from free primers and primer-dimers. A second PCR step attached dual indices and Illumina sequencing adapters using the Nextera XT Index Kit. Libraries were validated using the Agilent (Santa Clara, CA) 2100 Bioanalyzer to check size distribution. Indexed DNA libraries were normalized to 4 nmol/L and then pooled in equal volumes. The pool was loaded at a concentration of 9 pmol/L onto an Illumina Flowcell v2 with 20% of Phix control. The samples then were sequenced using the Illumina MiSeq, 2 × 250 bp paired end run. Quality control was performed using the FastQC tool (Illumina) and the Trimmomatic (USADELLAB, Aachen, Germany) software package was used. Sequenced paired-end reads were merged to reconstruct the original full-length 16S amplicons with PEAR software (by Prof. Alexandros Stamatakis, Heidelberg, Germany). All amplicons with sequence similarity higher than 97% were grouped together and a representative was chosen as input for the taxonomy annotation and building the operational taxonomic unit (OTU) table. Sequences were searched for matching in the SILVA taxonomy database (v128) using the open-reference OTU picking algorithm. The resulting OTU table was encoded in Biological observation Matrix format (http://biom-format.org/). The α-diversity (within sample) was investigated by means of 3 different indexes: Shannon, Simpson, and Fisher α index. Sample richness was investigated through Chao and phylogenetic diversity estimators. β-diversity was quantified using both OTU- and phylogenetic-based methods. The data set has been deposited in the Sequence Read Archive (accession no. SRP155816, https://www.ncbi.nlm.nih.gov/sra/SRP155816).
Overnight Fasting Blood Glucose Measurement
Mice were exposed to drinking water supplemented with 5% MDX for 10 weeks. After a 15-hour fast, baseline blood glucose levels were measured using the One touch Verio Flex Glucose Meter (Burnaby, BC, Canada) and expressed as mg/dL.
Statistical Analysis
Parametric data were analyzed using the 2-tailed Student t test for comparison between 2 groups or 1-way analysis of variance followed by the Bonferroni post hoc test for multiple comparisons. Nonparametric data were analyzed using the Mann–Whitney U test for comparison between 2 groups or the Kruskal–Wallis test for multiple comparisons. Significance was defined as a P value less than .05.
Acknowledgments
The authors thank V. Iebba (Department of Public Health and Infectious Diseases, Institute Pasteur Cenci Bolognetti Foundation, University of Rome La Sapienza) and S. Barbaliscia (Department of Experimental Medicine and Surgery, University of Rome Tor Vergata) for assistance in microbiota analysis, and M. Levrero (Department of Internal Medicine, University of Rome La Sapienza) for data discussion.
Footnotes
Author contributions F. Laudisi was responsible for the study concept and design, technical and material support, acquisition of data, analysis and interpretation of data, drafting the manuscript, and statistical analysis; D. Di Fusco was responsible for the analysis and interpretation of data, acquisition of data, and technical and material support; V. Dinallo, A. Di Grazia, I. Marafini, A. Colantoni, A. Ortenzi, M. Mavilio, and F. Guerrieri were responsible for technical and material support; C. Stolfi was responsible for the analysis and interpretation of data, and technical and material support; C. Alteri was responsible for the interpretation of data and technical and material support; F. Ceccherini-Silberstein was responsible for the analysis and interpretation of data and critical revision of the manuscript; M. Federici and T. T. MacDonald were responsible for critical revision of the manuscript; I. Monteleone was responsible for the analysis and interpretation of data and critical revision of the manuscript; and Giovanni Monteleone was responsible for the study concept and design, analysis and interpretation of data, and drafting and critical revision of the manuscript. All authors had access to all data and reviewed and approved the final manuscript.
Conflicts of interest The authors disclose no conflicts.
Funding This work was supported in part by the Ministry of Education, Universities and Research (Bandiera InterOmics Protocollo PB05 1°).
References
- 1.Abraham C., Cho J.H. Inflammatory bowel disease. N Engl J Med. 2009;361:2066–2078. doi: 10.1056/NEJMra0804647. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Bouma G., Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003;3:521–533. doi: 10.1038/nri1132. [DOI] [PubMed] [Google Scholar]
- 3.Jostins L., Ripke S., Weersma R.K., Duerr R.H., McGovern D.P., Hui K.Y., Lee J.C., Schumm L.P., Sharma Y., Anderson C.A., Essers J., Mitrovic M., Ning K., Cleynen I., Theatre E., Spain S.L., Raychaudhuri S., Goyette P., Wei Z., Abraham C., Achkar J.P., Ahmad T., Amininejad L., Ananthakrishnan A.N., Andersen V., Andrews J.M., Baidoo L., Balschun T., Bampton P.A., Bitton A., Boucher G., Brand S., Buning C., Cohain A., Cichon S., D'Amato M., De Jong D., Devaney K.L., Dubinsky M., Edwards C., Ellinghaus D., Ferguson L.R., Franchimont D., Fransen K., Gearry R., Georges M., Gieger C., Glas J., Haritunians T., Hart A., Hawkey C., Hedl M., Hu X., Karlsen T.H., Kupcinskas L., Kugathasan S., Latiano A., Laukens D., Lawrance I.C., Lees C.W., Louis E., Mahy G., Mansfield J., Morgan A.R., Mowat C., Newman W., Palmieri O., Ponsioen C.Y., Potocnik U., Prescott N.J., Regueiro M., Rotter J.I., Russell R.K., Sanderson J.D., Sans M., Satsangi J., Schreiber S., Simms L.A., Sventoraityte J., Targan S.R., Taylor K.D., Tremelling M., Verspaget H.W., De Vos M., Wijmenga C., Wilson D.C., Winkelmann J., Xavier R.J., Zeissig S., Zhang B., Zhang C.K., Zhao H., International I.B.D.G.C., Silverberg M.S., Annese V., Hakonarson H., Brant S.R., Radford-Smith G., Mathew C.G., Rioux J.D., Schadt E.E., Daly M.J., Franke A., Parkes M., Vermeire S., Barrett J.C., Cho J.H. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119–124. doi: 10.1038/nature11582. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Li X., Sundquist J., Hemminki K., Sundquist K. Risk of inflammatory bowel disease in first- and second-generation immigrants in Sweden: a nationwide follow-up study. Inflamm Bowel Dis. 2011;17:1784–1791. doi: 10.1002/ibd.21535. [DOI] [PubMed] [Google Scholar]
- 5.Molodecky N.A., Soon I.S., Rabi D.M., Ghali W.A., Ferris M., Chernoff G., Benchimol E.I., Panaccione R., Ghosh S., Barkema H.W., Kaplan G.G. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54 e42. doi: 10.1053/j.gastro.2011.10.001. quiz e30. [DOI] [PubMed] [Google Scholar]
- 6.Probert C.S., Jayanthi V., Hughes A.O., Thompson J.R., Wicks A.C., Mayberry J.F. Prevalence and family risk of ulcerative colitis and Crohn's disease: an epidemiological study among Europeans and south Asians in Leicestershire. Gut. 1993;34:1547–1551. doi: 10.1136/gut.34.11.1547. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Shoda R., Matsueda K., Yamato S., Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr. 1996;63:741–745. doi: 10.1093/ajcn/63.5.741. [DOI] [PubMed] [Google Scholar]
- 8.Ananthakrishnan A.N., Khalili H., Konijeti G.G., Higuchi L.M., de Silva P., Fuchs C.S., Willett W.C., Richter J.M., Chan A.T. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut. 2014;63:776–784. doi: 10.1136/gutjnl-2013-305304. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Khalili H., Ananthakrishnan A.N., Konijeti G.G., Higuchi L.M., Fuchs C.S., Richter J.M., Chan A.T. Measures of obesity and risk of Crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 2015;21:361–368. doi: 10.1097/MIB.0000000000000283. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Lewis J.D., Abreu M.T. Diet as a trigger or therapy for inflammatory bowel diseases. Gastroenterology. 2017;152:398–414 e6. doi: 10.1053/j.gastro.2016.10.019. [DOI] [PubMed] [Google Scholar]
- 11.Racine A., Carbonnel F., Chan S.S., Hart A.R., Bueno-de-Mesquita H.B., Oldenburg B., van Schaik F.D., Tjonneland A., Olsen A., Dahm C.C., Key T., Luben R., Khaw K.T., Riboli E., Grip O., Lindgren S., Hallmans G., Karling P., Clavel-Chapelon F., Bergman M.M., Boeing H., Kaaks R., Katzke V.A., Palli D., Masala G., Jantchou P., Boutron-Ruault M.C. Dietary patterns and risk of inflammatory bowel disease in Europe: results from the EPIC Study. Inflamm Bowel Dis. 2016;22:345–354. doi: 10.1097/MIB.0000000000000638. [DOI] [PubMed] [Google Scholar]
- 12.Devkota S., Wang Y., Musch M.W., Leone V., Fehlner-Peach H., Nadimpalli A., Antonopoulos D.A., Jabri B., Chang E.B. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature. 2012;487:104–108. doi: 10.1038/nature11225. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Martinez-Medina M., Denizot J., Dreux N., Robin F., Billard E., Bonnet R., Darfeuille-Michaud A., Barnich N. Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation. Gut. 2014;63:116–124. doi: 10.1136/gutjnl-2012-304119. [DOI] [PubMed] [Google Scholar]
- 14.Gulhane M., Murray L., Lourie R., Tong H., Sheng Y.H., Wang R., Kang A., Schreiber V., Wong K.Y., Magor G., Denman S., Begun J., Florin T.H., Perkins A., Cuiv P.O., McGuckin M.A., Hasnain S.Z. High fat diets induce colonic epithelial cell stress and inflammation that is reversed by IL-22. Sci Rep. 2016;6:28990. doi: 10.1038/srep28990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Monteleone I., Marafini I., Dinallo V., Di Fusco D., Troncone E., Zorzi F., Laudisi F., Monteleone G. Sodium chloride-enriched diet enhanced inflammatory cytokine production and exacerbated experimental colitis in mice. J Crohns Colitis. 2017;11:237–245. doi: 10.1093/ecco-jcc/jjw139. [DOI] [PubMed] [Google Scholar]
- 16.Tubbs A.L., Liu B., Rogers T.D., Sartor R.B., Miao E.A. Dietary salt exacerbates experimental colitis. J Immunol. 2017;199:1051–1059. doi: 10.4049/jimmunol.1700356. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Desai M.S., Seekatz A.M., Koropatkin N.M., Kamada N., Hickey C.A., Wolter M., Pudlo N.A., Kitamoto S., Terrapon N., Muller A., Young V.B., Henrissat B., Wilmes P., Stappenbeck T.S., Nunez G., Martens E.C. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell. 2016;167:1339–1353 e21. doi: 10.1016/j.cell.2016.10.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Mastrodonato M., Mentino D., Portincasa P., Calamita G., Liquori G.E., Ferri D. High-fat diet alters the oligosaccharide chains of colon mucins in mice. Histochem Cell Biol. 2014;142:449–459. doi: 10.1007/s00418-014-1221-2. [DOI] [PubMed] [Google Scholar]
- 19.Chassaing B., Koren O., Goodrich J.K., Poole A.C., Srinivasan S., Ley R.E., Gewirtz A.T. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015;519:92–96. doi: 10.1038/nature14232. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Nickerson K.P., Homer C.R., Kessler S.P., Dixon L.J., Kabi A., Gordon I.O., Johnson E.E., de la Motte C.A., McDonald C. The dietary polysaccharide maltodextrin promotes Salmonella survival and mucosal colonization in mice. PLoS One. 2014;9:e101789. doi: 10.1371/journal.pone.0101789. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Nickerson K.P., McDonald C. Crohn's disease-associated adherent-invasive Escherichia coli adhesion is enhanced by exposure to the ubiquitous dietary polysaccharide maltodextrin. PLoS One. 2012;7:e52132. doi: 10.1371/journal.pone.0052132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Suez J., Korem T., Zeevi D., Zilberman-Schapira G., Thaiss C.A., Maza O., Israeli D., Zmora N., Gilad S., Weinberger A., Kuperman Y., Harmelin A., Kolodkin-Gal I., Shapiro H., Halpern Z., Segal E., Elinav E. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 2014;514:181–186. doi: 10.1038/nature13793. [DOI] [PubMed] [Google Scholar]
- 23.Swidsinski A., Ung V., Sydora B.C., Loening-Baucke V., Doerffel Y., Verstraelen H., Fedorak R.N. Bacterial overgrowth and inflammation of small intestine after carboxymethylcellulose ingestion in genetically susceptible mice. Inflamm Bowel Dis. 2009;15:359–364. doi: 10.1002/ibd.20763. [DOI] [PubMed] [Google Scholar]
- 24.Thymann T., Moller H.K., Stoll B., Stoy A.C., Buddington R.K., Bering S.B., Jensen B.B., Olutoye O.O., Siggers R.H., Molbak L., Sangild P.T., Burrin D.G. Carbohydrate maldigestion induces necrotizing enterocolitis in preterm pigs. Am J Physiol Gastrointest Liver Physiol. 2009;297:G1115–G1125. doi: 10.1152/ajpgi.00261.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Chassaing B., Srinivasan G., Delgado M.A., Young A.N., Gewirtz A.T., Vijay-Kumar M. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PLoS One. 2012;7:e44328. doi: 10.1371/journal.pone.0044328. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Tsuru A., Fujimoto N., Takahashi S., Saito M., Nakamura D., Iwano M., Iwawaki T., Kadokura H., Ron D., Kohno K. Negative feedback by IRE1beta optimizes mucin production in goblet cells. Proc Natl Acad Sci U S A. 2013;110:2864–2869. doi: 10.1073/pnas.1212484110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Perez-Vilar J., Hill R.L. The structure and assembly of secreted mucins. J Biol Chem. 1999;274:31751–31754. doi: 10.1074/jbc.274.45.31751. [DOI] [PubMed] [Google Scholar]
- 28.Heazlewood C.K., Cook M.C., Eri R., Price G.R., Tauro S.B., Taupin D., Thornton D.J., Png C.W., Crockford T.L., Cornall R.J., Adams R., Kato M., Nelms K.A., Hong N.A., Florin T.H., Goodnow C.C., McGuckin M.A. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med. 2008;5:e54. doi: 10.1371/journal.pmed.0050054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Han J., Lee J.D., Bibbs L., Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 1994;265:808–811. doi: 10.1126/science.7914033. [DOI] [PubMed] [Google Scholar]
- 30.Itoh T., Yamauchi A., Miyai A., Yokoyama K., Kamada T., Ueda N., Fujiwara Y. Mitogen-activated protein kinase and its activator are regulated by hypertonic stress in Madin-Darby canine kidney cells. J Clin Invest. 1994;93:2387–2392. doi: 10.1172/JCI117245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Robinson A.M., Rahman A.A., Carbone S.E., Randall-Demllo S., Filippone R., Bornstein J.C., Eri R., Nurgali K. Alterations of colonic function in the Winnie mouse model of spontaneous chronic colitis. Am J Physiol Gastrointest Liver Physiol. 2017;312:G85–G102. doi: 10.1152/ajpgi.00210.2016. [DOI] [PubMed] [Google Scholar]
- 32.Van der Sluis M., De Koning B.A., De Bruijn A.C., Velcich A., Meijerink J.P., Van Goudoever J.B., Buller H.A., Dekker J., Van Seuningen I., Renes I.B., Einerhand A.W. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology. 2006;131:117–129. doi: 10.1053/j.gastro.2006.04.020. [DOI] [PubMed] [Google Scholar]
- 33.Velcich A., Yang W., Heyer J., Fragale A., Nicholas C., Viani S., Kucherlapati R., Lipkin M., Yang K., Augenlicht L. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science. 2002;295:1726–1729. doi: 10.1126/science.1069094. [DOI] [PubMed] [Google Scholar]
- 34.Martino M.B., Jones L., Brighton B., Ehre C., Abdulah L., Davis C.W., Ron D., O'Neal W.K., Ribeiro C.M. The ER stress transducer IRE1beta is required for airway epithelial mucin production. Mucosal Immunol. 2013;6:639–654. doi: 10.1038/mi.2012.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Lee J.C., Young P.R. Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J Leukoc Biol. 1996;59:152–157. doi: 10.1002/jlb.59.2.152. [DOI] [PubMed] [Google Scholar]
- 36.Geiger P.C., Wright D.C., Han D.H., Holloszy J.O. Activation of p38 MAP kinase enhances sensitivity of muscle glucose transport to insulin. Am J Physiol Endocrinol Metab. 2005;288:E782–E788. doi: 10.1152/ajpendo.00477.2004. [DOI] [PubMed] [Google Scholar]
- 37.Guo L.X., Xie H. Differential phosphorylation of p38 induced by apoptotic and anti-apoptotic stimuli in murine hepatocytes. World J Gastroenterol. 2005;11:1345–1350. doi: 10.3748/wjg.v11.i9.1345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Liang K.C., Lee C.W., Lin W.N., Lin C.C., Wu C.B., Luo S.F., Yang C.M. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells. J Cell Physiol. 2007;211:759–770. doi: 10.1002/jcp.20992. [DOI] [PubMed] [Google Scholar]
- 39.Kim S.J., Ko W.K., Jo M.J., Arai Y., Choi H., Kumar H., Han I.B., Sohn S. Anti-inflammatory effect of tauroursodeoxycholic acid in RAW 264.7 macrophages, bone marrow-derived macrophages, BV2 microglial cells, and spinal cord injury. Sci Rep. 2018;8:3176. doi: 10.1038/s41598-018-21621-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Wang W., Zhao J., Gui W., Sun D., Dai H., Xiao L., Chu H., Du F., Zhu Q., Schnabl B., Huang K., Yang L., Hou X. Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease. Br J Pharmacol. 2018;175:469–484. doi: 10.1111/bph.14095. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Eri R.D., Adams R.J., Tran T.V., Tong H., Das I., Roche D.K., Oancea I., Png C.W., Jeffery P.L., Radford-Smith G.L., Cook M.C., Florin T.H., McGuckin M.A. An intestinal epithelial defect conferring ER stress results in inflammation involving both innate and adaptive immunity. Mucosal Immunol. 2011;4:354–364. doi: 10.1038/mi.2010.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Ruiz P.A., Moron B., Becker H.M., Lang S., Atrott K., Spalinger M.R., Scharl M., Wojtal K.A., Fischbeck-Terhalle A., Frey-Wagner I., Hausmann M., Kraemer T., Rogler G. Titanium dioxide nanoparticles exacerbate DSS-induced colitis: role of the NLRP3 inflammasome. Gut. 2017;66:1216–1224. doi: 10.1136/gutjnl-2015-310297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Johansson M.E., Larsson J.M., Hansson G.C. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4659–4665. doi: 10.1073/pnas.1006451107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Johansson M.E., Phillipson M., Petersson J., Velcich A., Holm L., Hansson G.C. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A. 2008;105:15064–15069. doi: 10.1073/pnas.0803124105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Johansson M.E., Sjovall H., Hansson G.C. The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol. 2013;10:352–361. doi: 10.1038/nrgastro.2013.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Johansson M.E., Gustafsson J.K., Holmen-Larsson J., Jabbar K.S., Xia L., Xu H., Ghishan F.K., Carvalho F.A., Gewirtz A.T., Sjovall H., Hansson G.C. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut. 2014;63:281–291. doi: 10.1136/gutjnl-2012-303207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Bergstrom K.S., Kissoon-Singh V., Gibson D.L., Ma C., Montero M., Sham H.P., Ryz N., Huang T., Velcich A., Finlay B.B., Chadee K., Vallance B.A. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog. 2010;6:e1000902. doi: 10.1371/journal.ppat.1000902. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Kissoon-Singh V., Moreau F., Trusevych E., Chadee K. Entamoeba histolytica exacerbates epithelial tight junction permeability and proinflammatory responses in Muc2(-/-) mice. Am J Pathol. 2013;182:852–865. doi: 10.1016/j.ajpath.2012.11.035. [DOI] [PubMed] [Google Scholar]
- 49.Chassaing B., Van de Wiele T., De Bodt J., Marzorati M., Gewirtz A.T. Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation. Gut. 2017;66:1414–1427. doi: 10.1136/gutjnl-2016-313099. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Monteleone I., Federici M., Sarra M., Franze E., Casagrande V., Zorzi F., Cavalera M., Rizzo A., Lauro R., Pallone F., MacDonald T.T., Monteleone G. Tissue inhibitor of metalloproteinase-3 regulates inflammation in human and mouse intestine. Gastroenterology. 2012;143:1277–1287 e1-4. doi: 10.1053/j.gastro.2012.07.016. [DOI] [PubMed] [Google Scholar]
- 51.Dohi T., Ejima C., Kato R., Kawamura Y.I., Kawashima R., Mizutani N., Tabuchi Y., Kojima I. Therapeutic potential of follistatin for colonic inflammation in mice. Gastroenterology. 2005;128:411–423. doi: 10.1053/j.gastro.2004.11.063. [DOI] [PubMed] [Google Scholar]